fashion -WSS

fashion

author：fashion 2025-09-30 09:29:46 - browse：195

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Physician subsidies by hospitals soar in wake of No Surprises Act

hotspot

WSS

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

Health tech investors get more selective as pandemic boom fades

STAT Summit: How researchers deal with rejection

Paying for Covid pills will soon shift to insurers

Roivant's CEO is a star, but biotech's black hole persists

Wikipedia

fashion

focus

Trump demands the U.S. pay no more for drugs than other countries … again

The problems with dementia villages

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Cassava Sciences’ Alzheimer’s clinical trials should be halted

After affirmative action ruling, medical educators look to 'holistic review'

Biden's order seeks to regulate AI risk without stifling innovation

After affirmative action ruling, medical educators look to 'holistic review'

Cassava Sciences’ Alzheimer’s clinical trials should be halted

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Wikipedia

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Paying for Covid pills will soon shift to insurers

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Cassava reveals details — and problems — with Alzheimer's study

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Meta's Zuckerberg and Chan on track to put $50 billion into science

entertainment

Wikipedia

hotspot

focus